Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
31.9%
% of CANC's 47 holdings also in IDNA
33.3%
% of IDNA's 49 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 5.3% | 5.9% | 5.3% |
|
INCYTE CORP | 4.3% | 4.9% | 4.3% |
|
REVOLUTION MEDICINES, INC. | 4.2% | 4.7% | 4.2% |
|
EXELIXIS INC | 3.6% | 6.7% | 3.6% |
|
REGENERON PHARMACEUTICALS | 5.0% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IDNA
 |
ASTRAZENECA PLC | 5.6% |
 |
ARGENX SE ADR | 4.6% |
|
ILLUMINA INC | 4.2% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.6% |
|
BLUEPRINT MEDICINES CORP. | 3.1% |
|
DAIICHI SANKYO CO LTD | 3.0% |
|
GUARDANT HEALTH, INC. | 2.6% |
 |
GENMAB A/S SPONSORED ADR | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
 |
NOVARTIS AG | 2.1% |
CANC Underweight Relative to IDNA
 |
BEIGENE, LTD. | -4.8% |
|
ROCHE HOLDING LTD | -4.4% |
|
SAREPTA THERAPEUTICS INC | -4.2% |
|
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
 |
BIONTECH SE SPONSORED ADR | -3.9% |
|
GSK PLC | -3.4% |
|
EXELIXIS INC | -3.2% |
|
TWIST BIOSCIENCE CORP. | -3.1% |
|
GENMAB A/S | -3.0% |